{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:49:25Z","timestamp":1791496165165,"version":"4.3.4"},"reference-count":19,"publisher":"Informa UK Limited","issue":"sup3","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2003,11,1]]},"DOI":"10.1080\/1120009x.2003.11782356","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T06:32:31Z","timestamp":1477549951000},"page":"5-10","source":"Crossref","is-referenced-by-count":1,"title":["What is the Role of Fluoroquinolones in Intensive Care?"],"prefix":"10.1080","volume":"15","author":[{"given":"P.","family":"Viale","sequence":"first","affiliation":[{"name":"Clinic for Infectious Diseases, Department of Medical and Morphological Research, Medical School, University of Udine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pea","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology and Toxicology, Department of Pathology and Experimental and Clinical Medicine, Medical School, University of Udine","place":["Edgbaston, Birmingham, Italy."]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","unstructured":"Preston SL Drusano GL Berman AL et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. Jama 1998; 279 (2): 125\u2013129.","DOI":"10.1001\/jama.279.2.125"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Forrest A Nix DE Ballow CH Goss TF Birmingham MC Schentag JJ. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 1993; 37 (5): 1073\u20131081.","DOI":"10.1128\/AAC.37.5.1073"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Ambrose PG Grasela DM Grasela TH Passarell J Mayer HB Pierce PF. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother 2001; 45 (10): 2793\u20132797.","DOI":"10.1128\/AAC.45.10.2793-2797.2001"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Wright DH Brown GH Peterson ML Rotschafer JC. Application of fluoroquinolone pharmacodynamics. J Antimicrob Chemother 2000; 46 (5): 669\u2013683.","DOI":"10.1093\/jac\/46.5.669"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"Geddes A Thaler M Schonwald S Harkonen M Jacobs F Nowotny I. Levofloxacin in the empirical treatment of patients with suspected bacteraemia\/sepsis: comparison with imipenem\/cilastatin in an open randomized trial. J Antimicrob Chemother 1999; 44 (6): 799\u2013810.","DOI":"10.1093\/jac\/44.6.799"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Peacock JE Herrington DA Wade JC et al. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized double-blind trial. Ann Intern Med 2002; 137 (2): 77\u201387.","DOI":"10.7326\/0003-4819-137-2-200207160-00005"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Niederman MS Mandell LA Anzueto A et al. Guidelines for the management of adults with communityacquired pneumonia. Diagnosis assessment of severity antimicrobial therapy and prevention. Am J Respir Crit Care Med 2001; 163 (7): 1730\u20131754.","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","unstructured":"American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis assessment of severity initial antimicrobial therapy and preventive strategies. A consensus statement American Thoracic Society November 1995. Am J Respir Crit Care Med 1996; 153 (5): 1711\u20131725.","DOI":"10.1164\/ajrccm.153.5.8630626"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","unstructured":"Barcenilla F Gasco E Rello J Alvarez-Rocha L. Antibacterial treatment of invasive mechanical ventilation-associated pneumonia. Drugs Aging 2001; 18 (3): 189\u2013200.","DOI":"10.2165\/00002512-200118030-00004"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Pea F Di Qual E Cusenza A Brollo L Baldassarre M Furlanut M. Pharmacokinetics and pharmacodynamics of levofloxacin 500 mg bid IV in ICU patients with early-onset ventilator- associated pneumonia. Clin Pharmacokinet 2003; 42 (6): 589\u2013598.","DOI":"10.2165\/00003088-200342060-00008"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Langtry HD Lamb HM. Levofloxacin. Its use in infections of the respiratory tract skin soft tissues and urinary tract. Drugs 1998; 56 (3): 487\u2013515.","DOI":"10.2165\/00003495-199856030-00013"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","unstructured":"Furlanut M Brollo L Lugatti E et al. Pharmacokinetic aspects of levofloxacin 500 mg once daily during sequential intravenous\/oral therapy in patients with lower respiratory tract infections. J Antimicrob Chemother 2003; 51 (1): 101\u2013106.","DOI":"10.1093\/jac\/dkg035"},{"key":"e_1_2_1_14_1","unstructured":"Naber CK Hammer M Kinzig-Schippers M Sorgel F Naber KG. Urinary excretion and bactericidal activities of levofloxacin versus ciprofloxacin in healthy volunteers after a single oral dose of 500 mg. Abstract at the 9th Int Congress of Infectious Diseases Buenos Aires Argentina 2000; Poster 10920."},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"Naber KG. Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents 2001; 17 (4): 331\u2013341.","DOI":"10.1016\/S0924-8579(00)00362-9"},{"key":"e_1_2_1_16_1","unstructured":"Pea F Pavan F Di Qual E et al. Profilo delle concentrazioni urinarie di levofloxacina in pazienti ICU trattati con 500 mg bid per polmonite associata a ventilazione meccanica (VAP). Abstract al VI Convegno Nazionale IBAT Napoli 22-25 gennaio 2003; 242."},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"Lipman J Allworth A Wallis SC. Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis. Clin Infect Dis 2000; 31 (5): 1131\u20131133.","DOI":"10.1086\/317462"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","unstructured":"Scotton PG Pea F Giobbia M Baraldo M Vaglia A Furlanut M. Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. Clin Infect Dis 2001; 33 (9): e109\u2013111.","DOI":"10.1086\/323406"},{"key":"e_1_2_1_19_1","unstructured":"Pea F Pavan F Nascimben E et al. Farmacocinetica di levofloxacina nel liquido cerebrospinale di pazienti con ventricolostomia esterna. Abstract al VI Convegno Nazionale IBAT Napoli 22-25 gennaio 2003; 241."},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"Lutsar I Friedland IR. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid. Clin Pharmacokinet 2000; 39 (5): 335\u2013343.","DOI":"10.2165\/00003088-200039050-00003"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1120009X.2003.11782356","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1120009X.2003.11782356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:58:30Z","timestamp":1791493110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1120009X.2003.11782356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,1]]},"references-count":19,"journal-issue":{"issue":"sup3","published-print":{"date-parts":[[2003,11,1]]}},"alternative-id":["10.1080\/1120009X.2003.11782356"],"URL":"https:\/\/doi.org\/10.1080\/1120009x.2003.11782356","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11,1]]}}}